Lyon-University Hospital Experience with Gemtuzumab Ozogamicin Therapy in Acute Myeloid Leukemia: a ‘Real-Life’ Study

Ninety-four adults with newly diagnosed or relapsed/refractory acute myeloid leukemia (AML) were treated with fractionated doses of gemtuzumab ozogamicin (GO) at one-single French center over ten years. We attempted to define predictive factors for response and survival. The overall response rate wa...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Mediterr J Hematol Infect Dis
Hlavní autoři: Laurino, Marica, Loron, Sandrine, Larcher, Marie-Virginie, Fossard, Gaëlle, Elhamri, Mohamed, Deloire, Alexandre, Balsat, Marie, Barraco, Fiorenza, Labussière, Hélène, Ducastelle, Sophie, Renault, Myriam, Wattel, Eric, Heiblig, Maël, Salles, Gilles, Thomas, Xavier
Médium: Artigo
Jazyk:Inglês
Vydáno: Università Cattolica del Sacro Cuore 2020
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7202336/
https://ncbi.nlm.nih.gov/pubmed/32395209
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4084/MJHID.2020.020
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky